Literature DB >> 2244385

Herpes zoster ophthalmicus--the changing epidemiology and its implications for treatment.

S R Seiff, A M Mehta.   

Abstract

Mesh：

Year:  1990        PMID： 2244385      PMCID： PMC1002590     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  5 in total

1.  Complications of herpes zoster ophthalmicus.

Authors:  L W Womack; T J Liesegang
Journal:  Arch Ophthalmol       Date:  1983-01

Review 2.  Varicella zoster virus infections in immunocompromised hosts. A review of the natural history and management.

Authors:  H H Balfour
Journal:  Am J Med       Date:  1988-08-29       Impact factor: 4.965

3.  Use of intravenous acyclovir for treatment of herpes zoster ophthalmicus in patients at risk for AIDS.

Authors:  S R Seiff; T Margolis; S H Graham; J J O'Donnell
Journal:  Ann Ophthalmol       Date:  1988-12

4.  Risk of AIDS after herpes zoster.

Authors:  M Melbye; R J Grossman; J J Goedert; M E Eyster; R J Biggar
Journal:  Lancet       Date:  1987-03-28       Impact factor: 79.321

5.  Severe herpes zoster ophthalmicus in young African adults: a marker for HTLV-III seropositivity.

Authors:  P Kestelyn; A M Stevens; E Bakkers; D Rouvroy; P Van de Perre
Journal:  Br J Ophthalmol       Date:  1987-11       Impact factor: 4.638
  5 in total
  2 in total

1.  Incidence of herpes zoster ophthalmicus: results from the Pacific Ocular Inflammation Study.

Authors:  Durga S Borkar; Vivien M Tham; Elizabeth Esterberg; Kathryn J Ray; Aleli C Vinoya; John V Parker; Aileen Uchida; Nisha R Acharya
Journal:  Ophthalmology       Date:  2012-12-01       Impact factor: 12.079

2.  Prognostic value of Hutchinson's sign in acute herpes zoster ophthalmicus.

Authors:  Michel J W Zaal; Hennie J Völker-Dieben; Joe D'Amaro
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-02-11       Impact factor: 3.535
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.